Skip to main content

Table 1 Clinicopathological characteristics between CDX2-high and CDX2-low colorectal cancer

From: Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis

Variable Total (n = 396) CDX2 expression P value
High (n = 360) Low (n = 36)
Agea
65 234 (59.1) 211 (58.6) 23 (63.9) 0.60
 65 < 162 (40.9) 149 (41.4) 13 (36.1)  
Sexa
 Female 136 (34.3) 122 (33.9) 14 (38.9) 0.58
 Male 260 (65.7) 238 (66.1) 22 (61.1)  
Histologya
 Well 63 (15.9) 56 (15.6) 7 (19.4) 0.02
 Mod 315 (79.5) 291 (81.1) 24 (66.7)  
 Por 18 (4.5) 13 (3.6) 5 (13.9)  
Tumor location of the primary sitea
 Right 93 (23.5) 82 (22.8) 11 (30.6) 0.56
 Left 155 (39.1) 143 (39.7) 12 (33.3)  
 Rectum 148 (37.4) 135 (37.5) 13 (36.1)  
Number of metastasisb 4.5 (± 6.3) 4.5 (± 6.3) 4.9 (± 5.5) 0.68
Liver metastasisa
 Synchronous 223 (56.3) 207 (57.5) 16 (44.4) 0.16
 Metachronous 173 (43.7) 153 (42.5) 20 (55.6)  
Pre- or post-operative chemotherapya
 No 125 (31.6) 114 (31.7) 11 (30.6) 1.00
 Yes 271 (68.4) 246 (68.3) 25 (69.4)  
  1. Abbreviations: well Well differentiated, mod Moderately differentiated, por Poorly differentiated
  2. aData presented as n (%)
  3. bData presented as mean (± standard deviation)